A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2015

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Registrational; Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 25 Apr 2015 Results of pooled and subgroup analysis presented at the 67th Annual Meeting of the American Academy of Neurology.
    • 20 Oct 2009 Patient numbers amended from 469 to 654 as reported by ClinicalTrials.gov.
    • 01 Aug 2009 Primary endpoint 'Likert Scale' has not been met; results were published in the Journal of Pain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top